{"product_id":"the-passmachine-consultation-liaison-psychiatry-board-review-2020","title":"The PassMachine Consultation-Liaison Psychiatry Board Review 2020","description":"\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003ch3\u003eThe PassMachine Consultation-Liaison Psychiatry Board Review 2020\u003c\/h3\u003e\r\n‘‘\u003cstrong\u003eHere’s the challenge:\u003c\/strong\u003e this Consultation-Liaison Psychiatry review features 50.5 hours of laser-focused lectures and 900+ Q Bank questions, but all that great content means nothing if you don’t get through it in time for the exam. So, \u003cem\u003eBeat The Boards!\u003c\/em\u003e makes your prep easy\r\n\r\n\u003cstrong\u003eIntended Audience: \u003c\/strong\u003ePsychiatrists\r\n\r\n\u003cstrong\u003eLearning Objectives:\u003c\/strong\u003e\r\nUpon completion of this program, participants should be able to conduct, discuss, and describe:\r\n\u003cul\u003e\r\n \t\u003cli\u003e- Assessment and screening of eating and feeding disorders\u003c\/li\u003e\r\n \t\u003cli\u003e- Assessment and management of psychosomatic aspects of select heart diseases and psychiatric syndromes in heart disease\u003c\/li\u003e\r\n \t\u003cli\u003e- Management of substance-related and addictive disorders\u003c\/li\u003e\r\n \t\u003cli\u003e- Normal sexual function and age-related changes, general assessment and management approaches for sexual dysfunctions, gender dysphoria, paraphilic disorders\u003c\/li\u003e\r\n \t\u003cli\u003e‘‘Here’s The Challenge: this Consultation-Liaison Psychiatry review features 50.5 hours of laser-focused lectures and 900+ Q Bank questions, but all that great content means nothing if you don’t get through it in time for the exam. So, Beat The Boards! makes your prep easy\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eIntended Audience: Psychiatrists\u003c\/h3\u003e\r\n\u003ch3\u003eLearning Objectives:\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eUpon completion of this program, participants should be able to conduct, discuss, and describe:\u003c\/li\u003e\r\n \t\u003cli\u003e- Assessment and screening of eating and feeding disorders\u003c\/li\u003e\r\n \t\u003cli\u003e- Assessment and management of psychosomatic aspects of select heart diseases and psychiatric syndromes in heart disease\u003c\/li\u003e\r\n \t\u003cli\u003e- Management of substance-related and addictive disorders\u003c\/li\u003e\r\n \t\u003cli\u003e- Normal sexual function and age-related changes, general assessment and management approaches for sexual dysfunctions, gender dysphoria, paraphilic disorders\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003eTopics:\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e- 01A Psychiatric Disorders in Chronic Kidney Disease I\u003c\/div\u003e\r\n\u003cdiv\u003e- 01B Psychiatric Disorders in Chronic Kidney Disease II\u003c\/div\u003e\r\n\u003cdiv\u003e- 01C Psychiatric Disorders in Chronic Kidney Disease III\u003c\/div\u003e\r\n\u003cdiv\u003e- 02A Neurology I- Cortical Syndromes\u003c\/div\u003e\r\n\u003cdiv\u003e- 02B Neurology II- Movement Disorders \u0026amp; Stroke\u003c\/div\u003e\r\n\u003cdiv\u003e- 02C Neurology III- Seizures \u0026amp; Headaches\u003c\/div\u003e\r\n\u003cdiv\u003e- 03A Endocrine I- Diabetes Mellitus\u003c\/div\u003e\r\n\u003cdiv\u003e- 03B Endocrine II- Thyroid and Parathyroid Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 03C Endocrine III- Parathyroid and Adrenal Diseases, Pheochromocytoma, and Osteoporosis\u003c\/div\u003e\r\n\u003cdiv\u003e- 03D Endocrine IV- Assessment and Management of Psychosomatic Aspects of Select Endocrine Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 04A Surgery and Surgical Critical Care I- Role of Psychiatrist and Preoperative Psychiatric Evaluations\u003c\/div\u003e\r\n\u003cdiv\u003e- 04B Surgery and Surgical Critical Care II- Preoperative and Perioperative Issues\u003c\/div\u003e\r\n\u003cdiv\u003e- 04C Surgery and Surgical Critical Care III- Postoperative Issues, Management of Psychiatric Disorders on Surgical and Intensive Care Units, ICU Delirium, and Burn Patients\u003c\/div\u003e\r\n\u003cdiv\u003e- 05A Obstetrics and Gynecology I- Introduction to Obstetrics and Gynecology and Psychiatric Comorbidities in OB_GYN Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 05B Obstetrics and Gynecology II- Assessment and Management of Psychosomatic Aspects of Select OB_GYN Conditions\u003c\/div\u003e\r\n\u003cdiv\u003e- 05C Obstetrics and Gynecology III- Assessment and Management of Psychosomatic Aspects of Select OB_GYN Conditions\u003c\/div\u003e\r\n\u003cdiv\u003e- 06 Rheumatology\u003c\/div\u003e\r\n\u003cdiv\u003e- 07A Dermatology I- General Assessment Approaches, General Management Approaches, and Dermatologic Manifestations of Psychiatric Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 07B Dermatology II- Psychological Factors in Dermatologic Diseases and in Their Treatment, Factitious Disorders, and Prescribing Guidelines\u003c\/div\u003e\r\n\u003cdiv\u003e- 08A Heart I- Assessment and Management of Psychosomatic Aspects of Select Heart Diseases and Psychiatric Syndromes in Heart Disease\u003c\/div\u003e\r\n\u003cdiv\u003e- 08B Heart II- Psychological Factors in Heart Disease and its Treatment and Psychiatric Assessment in the Context of Heart Disease\u003c\/div\u003e\r\n\u003cdiv\u003e- 08C Heart III- Psychiatric Management in the Context of Heart Disease and Prescribing Guidelines\u003c\/div\u003e\r\n\u003cdiv\u003e- 09A Pain I- Introduction, Epidemiology of Pain Conditions and Scope of Pain-killer Epidemic, Neurobiology, Cognitive and Emotional Factors\u003c\/div\u003e\r\n\u003cdiv\u003e- 09B Pain II- Pain Assessment_Pain Scales and Assessment and Management of Psychosomatic Aspects of Select Pain Conditions\u003c\/div\u003e\r\n\u003cdiv\u003e- 09C Pain III- Psychiatric Comorbidities and Differential Diagnoses, Pharmacologic and Other Somatic Interventions, Psychosocial Treatment Interventions, and Other Topics\u003c\/div\u003e\r\n\u003cdiv\u003e- 10A Transplant Psychiatry I- Pre-transplant Evaluation\u003c\/div\u003e\r\n\u003cdiv\u003e- 10B Transplant Psychiatry II- Post-transplant Management\u003c\/div\u003e\r\n\u003cdiv\u003e- 11A Palliative Medicine I- Introduction to Palliative Medicine and Managing Psychiatric Disorders in the Palliative Setting\u003c\/div\u003e\r\n\u003cdiv\u003e- 11B Palliative Medicine II- Psychological Interventions, Spirituality, Working with Families, Interdisciplinary Issues, Grief, Grief Therapy, and Bereavement\u003c\/div\u003e\r\n\u003cdiv\u003e- 12A Pulmonary Disorders I- Assessment and Management of Psychosomatic Aspects of Select Pulmonary Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 12B Pulmonary Disorders II- Assessment and Management of Psychosomatic Aspects of Select Pulmonary Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 12C Pulmonary Disorders III- Psychiatric Assessment and Management in the Context of Pulmonary Disease\u003c\/div\u003e\r\n\u003cdiv\u003e- 13A Gastrointestinal Disorders I- Assessment and Management of Select GI Syndromes\u003c\/div\u003e\r\n\u003cdiv\u003e- 13B Gastrointestinal Disorders II- Hepatitis, Drug Induced Liver Disease and Liver Transplantation\u003c\/div\u003e\r\n\u003cdiv\u003e- 13C Gastrointestinal Disorders III- Pancreatic Disorders, Psychiatric Management in Liver Disease and Psychological Factors in GI Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 14A Legal Issues- Part I\u003c\/div\u003e\r\n\u003cdiv\u003e- 14B Legal Issues- Part II\u003c\/div\u003e\r\n\u003cdiv\u003e- 15 Ethics and Practice Issues\u003c\/div\u003e\r\n\u003cdiv\u003e- 16A Psychoncology I- Psychiatric Syndromes Present in Cancer, Psychological Factors in Cancer and in its treatment, and Psychiatric Assessment\u003c\/div\u003e\r\n\u003cdiv\u003e- 16B Psychoncology II- Psychiatric Management in the Context of Cancer, Medication Use and Adverse Effects in Context of Cancer and Psychiatric Morbidity\u003c\/div\u003e\r\n\u003cdiv\u003e- 17A Pediatric Psychiatry I- General Psychiatric Assessment and Management Approaches\u003c\/div\u003e\r\n\u003cdiv\u003e- 17B Pediatric Psychiatry II- Assessment and Management of Psychosomatic Aspects of Select Pediatric Conditions and Prescribing Guidelines- Psychiatric Management In Context of Neurologic Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 18A Psychosomatic Topics in Physical Medicine and Rehabilitation I- Introduction, Traumatic Brain Injury, and Principles of Cognitive Rehabilitation\u003c\/div\u003e\r\n\u003cdiv\u003e- 18B Psychosomatic Topics in Physical Medicine and Rehabilitation II- Spinal Cord Injury, Paralysis, and Neuromuscular Condition\u003c\/div\u003e\r\n\u003cdiv\u003e- 19 Special Topics for the Psychosomatic Medicine Course\u003c\/div\u003e\r\n\u003cdiv\u003e- 20A Hematology I\u003c\/div\u003e\r\n\u003cdiv\u003e- 20B Hematology II\u003c\/div\u003e\r\n\u003cdiv\u003e- 21A HIV_AIDS I- Basic Pathophysiology, Diagnosis, and Assessment\u003c\/div\u003e\r\n\u003cdiv\u003e- 21B HIV_AIDS II- Psychiatric Management\u003c\/div\u003e\r\n\u003cdiv\u003e- 21C HIV_AIDS III- Relevant Psychological Factors and Pharmacologic Issues\u003c\/div\u003e\r\n\u003cdiv\u003e- 22A Chronic Fatigue Syndrome I- Basic Pathophysiology, Diagnosis, and Assessment\u003c\/div\u003e\r\n\u003cdiv\u003e- 22B Chronic Fatigue Syndrome II- Relevant Psychological Factors, Psychiatric Management, and Pharmacologic Issues\u003c\/div\u003e\r\n\u003cdiv\u003e- 23 Fibromyalgia Syndrome\u003c\/div\u003e\r\n\u003cdiv\u003e- 24A Assessment I- Consultation Overview, Cultural and Spiritual Issues\u003c\/div\u003e\r\n\u003cdiv\u003e- 24B Assessment II- Neuroimaging\u003c\/div\u003e\r\n\u003cdiv\u003e- 24C Assessment III- Neuropsychological Testing\u003c\/div\u003e\r\n\u003cdiv\u003e- 25A Delirium- Part I\u003c\/div\u003e\r\n\u003cdiv\u003e- 25B Delirium- Part II\u003c\/div\u003e\r\n\u003cdiv\u003e- 26A Neurocognitive Disorders I- Diagnostic Criteria and Classification\u003c\/div\u003e\r\n\u003cdiv\u003e- 26B Neurocognitive Disorders II- Diagnostic Assessment\u003c\/div\u003e\r\n\u003cdiv\u003e- 26C Neurocognitive Disorders III- General Management\u003c\/div\u003e\r\n\u003cdiv\u003e- 26D Neurocognitive Disorders IV- Review of Alzheimer's Disease\u003c\/div\u003e\r\n\u003cdiv\u003e- 26E Neurocognitive Disorders V- Review of Lewy Body and Vascular Disease\u003c\/div\u003e\r\n\u003cdiv\u003e- 26F Neurocognitive Disorders VI- Review of Frontal Temporal NCD and Infectious Diseases\u003c\/div\u003e\r\n\u003cdiv\u003e- 26G Neurocognitive Disorders VII- Review of Other Etiologies\u003c\/div\u003e\r\n\u003cdiv\u003e- 27 Psychological Reactions to Illness\u003c\/div\u003e\r\n\u003cdiv\u003e- 28A Depressive Disorders 1- Clinical Overview \u0026amp; Pathophysiology\u003c\/div\u003e\r\n\u003cdiv\u003e- 28B Depressive Disorders 2- Diagnosis and Assessment\u003c\/div\u003e\r\n\u003cdiv\u003e- 28C Depressive Disorders 3- Treatment Overview and SSRIs _SNRIs\u003c\/div\u003e\r\n\u003cdiv\u003e- 28D Depressive Disorders 4- Antidepressants and ECT\u003c\/div\u003e\r\n\u003cdiv\u003e- 28E Depressive Disorders 5- Somatic Treatments and Psychotherapies\u003c\/div\u003e\r\n\u003cdiv\u003e- 29A Bipolar Disorders I- Bipolar Disorder Diagnosis, Assessment of Bipolar Disorders and Secondary Bipolar Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 29B Bipolar Disorders II- Bipolar Disorders in Specific Medical Populations and Management of Bipolar Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 30A Suicide\u003c\/div\u003e\r\n\u003cdiv\u003e- 30B Violence and Aggression\u003c\/div\u003e\r\n\u003cdiv\u003e- 31A Schizophrenia Spectrum Disorders and Psychosis I- Epidemiology and Etiologies of Psychosis\u003c\/div\u003e\r\n\u003cdiv\u003e- 31B Schizophrenia Spectrum Disorders and Psychosis II- Assessment in the Medically Ill and Psychosis in Specific Medical Populations\u003c\/div\u003e\r\n\u003cdiv\u003e- 31C Schizophrenia Spectrum Disorders and Psychosis III- Review of Catatonic Syndrome and Catatonic Syndrome in Specific Medical Populations\u003c\/div\u003e\r\n\u003cdiv\u003e- 31D Schizophrenia Spectrum Disorders and Psychosis IV- Review of Specific Schizophrenia Spectrum Disorders and Specific Management Considerations of Psychosis in the Medically Ill\u003c\/div\u003e\r\n\u003cdiv\u003e- 32A Anxiety Disorders I- Anxiety Mechanisms and Evaluation\u003c\/div\u003e\r\n\u003cdiv\u003e- 32B Anxiety Disorders II- Review of Specific Anxiety Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 32C Anxiety Disorders III- Secondary Anxiety Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 32D Anxiety Disorders IV- Anxiety Presentations in Specific Medical Populations\u003c\/div\u003e\r\n\u003cdiv\u003e- 32E Anxiety Disorders V- Management of Anxiety\u003c\/div\u003e\r\n\u003cdiv\u003e- 32F Anxiety Disorders VI- Post Traumatic Stress Disorder\u003c\/div\u003e\r\n\u003cdiv\u003e- 33A Somatic Symptom and Related Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 33B Factitious Disorder and Malingering\u003c\/div\u003e\r\n\u003cdiv\u003e- 34A Eating and Feeding Disorders I- Overview of Eating and Feeding Disorders and Assessment and Screening\u003c\/div\u003e\r\n\u003cdiv\u003e- 34B Eating and Feeding Disorders II- Review of Specific Eating and Feeding Disorders- Diagnostic and Clinical Presentations, Epidemiology and Etiologies, Assessment and Management\u003c\/div\u003e\r\n\u003cdiv\u003e- 34C Eating and Feeding Disorders III- Specific Eating \u0026amp; Feeding Disorders- Diagnostic \u0026amp; Clinical Presentations, Epidemiology \u0026amp; Etiologies, Assessment \u0026amp; Management and Eating\u003c\/div\u003e\r\n\u003cdiv\u003e- 35A Sleep-Wake Disorders I\u003c\/div\u003e\r\n\u003cdiv\u003e- 35B Sleep-Wake Disorders II\u003c\/div\u003e\r\n\u003cdiv\u003e- 36A Sexual Dysfunctions, Gender Dysphoria, Paraphilic Disorders I- Normal Sexual Function and Age-Related Changes, General Assessment Approaches and General Management Approaches\u003c\/div\u003e\r\n\u003cdiv\u003e- 36B Sexual Dysfunctions, Gender Dysphoria, Paraphilic Disorders II- Specific Sexual Dysfunction Disorders, Specific Medical Populations, Gender Dysphoria and Paraphilic Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 37A Substance-related and Addictive Disorders I- Overview of Substance Related Disorders and Assessment in the Medically Ill\u003c\/div\u003e\r\n\u003cdiv\u003e- 37B Substance-related and Addictive Disorders II- Review of Alcohol – Sedative Use Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 37C Substance-related and Addictive Disorders III- Review of Opioid Use Disorders and Review of Stimulant Use Disorders\u003c\/div\u003e\r\n\u003cdiv\u003e- 37D Substance-related and Addictive Disorders IV- Nicotine Use Disorders, Cannabis Use Disorders, Other Drugs of Abuse and Impaired Health Care Providers\u003c\/div\u003e\r\n\u003cdiv\u003e- 38A Psychopharmacology I- Pharmacokinetics\u003c\/div\u003e\r\n\u003cdiv\u003e- 38B Psychopharmacology II- Pharmacodynamics\u003c\/div\u003e\r\n\u003cdiv\u003e- 38C Psychopharmacology III- Adverse Drug Reactions and Pregnancy-Related Issues\u003c\/div\u003e\r\n\u003cdiv\u003e- 38D Psychopharmacology IV- Prescribing Cautions and Drug-Drug Interactions\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003eRelease Date June 30, 2020\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954396663906,"sku":"MED-AMB02627","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/The-PassMachine-Consultation-Liaison-Psychiatry-Board-Review-2020_b53d791a-34ea-447e-b536-02d0fab4b30d.jpg?v=1779375342","url":"https:\/\/meducourse.com\/products\/the-passmachine-consultation-liaison-psychiatry-board-review-2020","provider":"Meducourse","version":"1.0","type":"link"}